Cargando…

Sequencing technology as a major impetus in the advancement of studies into rheumatism: A bibliometric study

BACKGROUND: Rheumatism covers a wide range of diseases with complex clinical manifestations and places a tremendous burden on humans. For many years, our understanding of rheumatism was seriously hindered by technology constraints. However, the increasing application and rapid advancement of sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Runzhi, Tang, Jieling, Wang, Siqiao, Liu, Yifan, Zhang, Mengyi, Jin, Minghao, Qin, Hengwei, Qian, Weijin, Lu, Yuwei, Yang, Yiting, Lu, Bingnan, Yao, Yuntao, Yan, Penghui, Huang, Jie, Zhang, Wei, Lu, Jianyu, Gu, Minyi, Zhu, Yushu, Guo, Xinya, Xian, Shuyuan, Liu, Xin, Huang, Zongqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982012/
https://www.ncbi.nlm.nih.gov/pubmed/36875117
http://dx.doi.org/10.3389/fimmu.2023.1067830
_version_ 1784900232461418496
author Huang, Runzhi
Tang, Jieling
Wang, Siqiao
Liu, Yifan
Zhang, Mengyi
Jin, Minghao
Qin, Hengwei
Qian, Weijin
Lu, Yuwei
Yang, Yiting
Lu, Bingnan
Yao, Yuntao
Yan, Penghui
Huang, Jie
Zhang, Wei
Lu, Jianyu
Gu, Minyi
Zhu, Yushu
Guo, Xinya
Xian, Shuyuan
Liu, Xin
Huang, Zongqiang
author_facet Huang, Runzhi
Tang, Jieling
Wang, Siqiao
Liu, Yifan
Zhang, Mengyi
Jin, Minghao
Qin, Hengwei
Qian, Weijin
Lu, Yuwei
Yang, Yiting
Lu, Bingnan
Yao, Yuntao
Yan, Penghui
Huang, Jie
Zhang, Wei
Lu, Jianyu
Gu, Minyi
Zhu, Yushu
Guo, Xinya
Xian, Shuyuan
Liu, Xin
Huang, Zongqiang
author_sort Huang, Runzhi
collection PubMed
description BACKGROUND: Rheumatism covers a wide range of diseases with complex clinical manifestations and places a tremendous burden on humans. For many years, our understanding of rheumatism was seriously hindered by technology constraints. However, the increasing application and rapid advancement of sequencing technology in the past decades have enabled us to study rheumatism with greater accuracy and in more depth. Sequencing technology has made huge contributions to the field and is now an indispensable component and powerful tool in the study of rheumatism. METHODS: Articles on sequencing and rheumatism, published from 1 January 2000 to 25 April 2022, were retrieved from the Web of Science™ (Clarivate™, Philadelphia, PA, USA) database. Bibliometrix, the open-source tool, was used for the analysis of publication years, countries, authors, sources, citations, keywords, and co-words. RESULTS: The 1,374 articles retrieved came from 62 countries and 350 institutions, with a general increase in article numbers during the last 22 years. The leading countries in terms of publication numbers and active cooperation with other countries were the USA and China. The most prolific authors and most popular documents were identified to establish the historiography of the field. Popular and emerging research topics were assessed by keywords and co-occurrence analysis. Immunological and pathological process in rheumatism, classification, risks and susceptibility, and biomarkers for diagnosis were among the hottest themes for research. CONCLUSIONS: Sequencing technology has been widely applied in the study of rheumatism and propells research in the area of discovering novel biomarkers, related gene patterns and physiopathology. We suggest that further efforts be made to advance the study of genetic patterns related to rheumatic susceptibility, pathogenesis, classification and disease activity, and novel biomarkers.
format Online
Article
Text
id pubmed-9982012
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99820122023-03-04 Sequencing technology as a major impetus in the advancement of studies into rheumatism: A bibliometric study Huang, Runzhi Tang, Jieling Wang, Siqiao Liu, Yifan Zhang, Mengyi Jin, Minghao Qin, Hengwei Qian, Weijin Lu, Yuwei Yang, Yiting Lu, Bingnan Yao, Yuntao Yan, Penghui Huang, Jie Zhang, Wei Lu, Jianyu Gu, Minyi Zhu, Yushu Guo, Xinya Xian, Shuyuan Liu, Xin Huang, Zongqiang Front Immunol Immunology BACKGROUND: Rheumatism covers a wide range of diseases with complex clinical manifestations and places a tremendous burden on humans. For many years, our understanding of rheumatism was seriously hindered by technology constraints. However, the increasing application and rapid advancement of sequencing technology in the past decades have enabled us to study rheumatism with greater accuracy and in more depth. Sequencing technology has made huge contributions to the field and is now an indispensable component and powerful tool in the study of rheumatism. METHODS: Articles on sequencing and rheumatism, published from 1 January 2000 to 25 April 2022, were retrieved from the Web of Science™ (Clarivate™, Philadelphia, PA, USA) database. Bibliometrix, the open-source tool, was used for the analysis of publication years, countries, authors, sources, citations, keywords, and co-words. RESULTS: The 1,374 articles retrieved came from 62 countries and 350 institutions, with a general increase in article numbers during the last 22 years. The leading countries in terms of publication numbers and active cooperation with other countries were the USA and China. The most prolific authors and most popular documents were identified to establish the historiography of the field. Popular and emerging research topics were assessed by keywords and co-occurrence analysis. Immunological and pathological process in rheumatism, classification, risks and susceptibility, and biomarkers for diagnosis were among the hottest themes for research. CONCLUSIONS: Sequencing technology has been widely applied in the study of rheumatism and propells research in the area of discovering novel biomarkers, related gene patterns and physiopathology. We suggest that further efforts be made to advance the study of genetic patterns related to rheumatic susceptibility, pathogenesis, classification and disease activity, and novel biomarkers. Frontiers Media S.A. 2023-02-17 /pmc/articles/PMC9982012/ /pubmed/36875117 http://dx.doi.org/10.3389/fimmu.2023.1067830 Text en Copyright © 2023 Huang, Tang, Wang, Liu, Zhang, Jin, Qin, Qian, Lu, Yang, Lu, Yao, Yan, Huang, Zhang, Lu, Gu, Zhu, Guo, Xian, Liu and Huang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Huang, Runzhi
Tang, Jieling
Wang, Siqiao
Liu, Yifan
Zhang, Mengyi
Jin, Minghao
Qin, Hengwei
Qian, Weijin
Lu, Yuwei
Yang, Yiting
Lu, Bingnan
Yao, Yuntao
Yan, Penghui
Huang, Jie
Zhang, Wei
Lu, Jianyu
Gu, Minyi
Zhu, Yushu
Guo, Xinya
Xian, Shuyuan
Liu, Xin
Huang, Zongqiang
Sequencing technology as a major impetus in the advancement of studies into rheumatism: A bibliometric study
title Sequencing technology as a major impetus in the advancement of studies into rheumatism: A bibliometric study
title_full Sequencing technology as a major impetus in the advancement of studies into rheumatism: A bibliometric study
title_fullStr Sequencing technology as a major impetus in the advancement of studies into rheumatism: A bibliometric study
title_full_unstemmed Sequencing technology as a major impetus in the advancement of studies into rheumatism: A bibliometric study
title_short Sequencing technology as a major impetus in the advancement of studies into rheumatism: A bibliometric study
title_sort sequencing technology as a major impetus in the advancement of studies into rheumatism: a bibliometric study
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982012/
https://www.ncbi.nlm.nih.gov/pubmed/36875117
http://dx.doi.org/10.3389/fimmu.2023.1067830
work_keys_str_mv AT huangrunzhi sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT tangjieling sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT wangsiqiao sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT liuyifan sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT zhangmengyi sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT jinminghao sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT qinhengwei sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT qianweijin sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT luyuwei sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT yangyiting sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT lubingnan sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT yaoyuntao sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT yanpenghui sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT huangjie sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT zhangwei sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT lujianyu sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT guminyi sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT zhuyushu sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT guoxinya sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT xianshuyuan sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT liuxin sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy
AT huangzongqiang sequencingtechnologyasamajorimpetusintheadvancementofstudiesintorheumatismabibliometricstudy